| Literature DB >> 33302936 |
Marta A Kisiel1, Sofia Kühner2, Karin Stolare3, Erik Lampa4, Martin Wohlin2, Nina Johnston4,5, Anna Rask-Andersen6.
Abstract
BACKGROUND: Gender discrimination (GD) and sexual harassment (SH) occur at all academic institutions worldwide. Medical students report high prevalence of GD and SH, which may negatively affect their education and health. There are indications that policies and reforms on reducing GD/SH are insufficient. Swedish medical students' experiences of GD/SH are monitored by course-evaluations and bi-annual student union evaluations; however, the response rate is usually low. The aim of this study was to compare the exposure to and context of self-reported GD/SH over an 11-year period amongst medical students at a Swedish university.Entities:
Keywords: Gender discrimination; Medical students; Sexual harassment; Swedish university
Mesh:
Year: 2020 PMID: 33302936 PMCID: PMC7731624 DOI: 10.1186/s12909-020-02422-9
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Total number of medical students that completed the questionnaire in 2002 and 2013, stratified by pre-clinical and clinical semesters, age, year, and gender. Percent (%) is the percent of all females and males or the percent of the total of medical students in the cohort from 2002 and 2013
| Semester | Age | 2002 | 2013 | ||||
|---|---|---|---|---|---|---|---|
| Females n (%) | Males n (%) | Total | Females n (%) | Males n (%) | Total | ||
| < 20 | 4 (2) | 1 (1) | 5 (1,5) | 24 (6) | 23 (8) | 47 (6,5) | |
| 20–25 | 75 (36) | 30 (22) | 105 (30,5) | 153 (36) | 89 (30,5) | 242 (33,5) | |
| 26–30 | 15 (7) | 12 (9) | 27 (8) | 11 (2,5) | 15 (5) | 26 (4) | |
| 31–35 | 7 (3) | 5 (4) | 12 (3,5) | 5 (1) | 4 (1,5) | 9 (1,5) | |
| 36–40 | 1 (0,5) | 0 () | 1 (0,5) | 2 (0) | 0 (0) | 2 (0) | |
| > 40 | 1 (0,5) | 1 (1) | 2 (0,5) | 0 (0) | 3 (1) | 3 (0,5) | |
| < 20 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| 20–25 | 65 (31) | 45 (34) | 110 (32) | 146 (34) | 90 (31) | 236 (32,5) | |
| 26–30 | 25 (12) | 28 (21) | 53 (15,5) | 64 (15,5) | 49 (17) | 113 (15,5) | |
| 31–35 | 9 (4) | 8 (6) | 17 (5) | 17 (4) | 9 (3) | 26 (4) | |
| 36–40 | 7 (3) | 2 (2) | 9 (3) | 6 (1) | 8 (2,5) | 14 (2) | |
| > 40 | 2 (1) | 0 (0) | 2 (0,5) | 0 (0) | 2 (0,5) | 2 (0) | |
Fig. 1Mean values shows the frequency of exposures to gender discrimination (GD) and sexual harassments (SH) experienced by female and male medical students at pre-clinical and clinical semesters in 2002 and 2013. Scale: Never = 0, Once = 1, More than once = 3
The medical students in the primary and secondary cohort, divided into pre-clinical and clinical courses as well as gender (female/male), were asked the question: “Did you notice other students being discriminated / favored /receiving unwelcome comments due to her/his gender?” Prevalence (percent) of the medical students who answered ‘yes’ to this question (weighted to represent the total population of medical students during 2002 and 2013, respectively). Ratios presented are the prevalence in 2013 divided by the prevalence in 2002, with corresponding 95% confidence intervals. A ratio > 1 indicates that the condition has an increased prevalence in 2013. The p-values result from tests where the null hypotheses are that the ratios are the same between the males and the females. Thus, a p-value < 0.5 indicates a statistically significant ratio between the sexes over the time period
| Did you notice that other students experienced ......due to her/his gender? | Cohort | Pre-clinical | Clinical | ||
|---|---|---|---|---|---|
| Females | Males | Females | Males | ||
| (… discrimination … | 26.6 | 10.5 | 42.6 | 31.1 | |
| 22.4 | 14.6 | 41.3 | 25.0 | ||
| Ratio (2013/2002) | 0.84 (0.67–1.06) | 1.39 (0.57–3.37) | 0.97 (0.81–1.17) | 0.80 (0.65–1.00) | |
| 0.246 | 0.244 | ||||
| … favoritism … | 31.6 | 18.6 | 66.4 | 42.8 | |
| 22.9 | 17.8 | 53.0 | 33.0 | ||
| Ratio (2013/2002) | 0.72 (0.61–0.86) | 0.95 (0.60–1.52) | 0.80 (0.73–0.88) | 0.77 (0.65–0.91) | |
| 0.369 | 0.785 | ||||
| …. intrusive unwelcome acts … ). | 19.7 | 16.4 | 27.1 | 32.6 | |
| 20.8 | 14.7 | 25.5 | 20.2 | ||
| Ratio (2013/2002) | 1.06 (0.75–1.48) | 0.89 (0.56–1.44) | 0.94 (0.73–1.20) | 0.62 (0.52–0.74) | |
| 0.596 | 0.040 | ||||
The stratification of the individuals reported as perpetrators (other student/supervisor or teacher/medical doctor/ nurse or other medical personnel) of sexual harassments. The medical students from the primary cohort (2002) and the revision cohort (2013) were stratified by pre-clinical and clinical semester and gender (females/males). Prevalence (percent) of the medical students who answered ‘yes’ to this question (weighted to represent the total population of medical students during 2002 and 2013, respectively). Ratios presented are the prevalence in 2013 divided by the prevalence in 2002, with corresponding 95% confidence intervals. A ratio > 1 indicates that the condition has an increased prevalence in 2013. The p-values result from tests where the null hypotheses are that the ratios are the same between the females and the males
| Semester | Gender | Cohort | Other student who was | Supervisor/teacher who was | Medical doctor who was | Nurse or other medical personnel who was | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Females | Males | Females | Males | Females | Males | Females | Males | |||
| Pre-clinical | 2002 (percent) | 25.2 | 41.2 | 22.0 | 48.2 | 4.2 | 8.6 | 4.2 | 4.2 | |
| 2013 (percent) | 28.6 | 37.9 | 23.1 | 29.3 | 11.4 | 14.1 | 7.9 | 7.5 | ||
| Ratio (2013/2002) | 1.14 (0.85–1.52) | 0.92 (0.77–1.09) | 1.05 (0.78–1.41) | 0.61 (0.55–0.68) | 2.70 (0.48–15.06) | 1.65 (0.75–3.60) | 1.86 (0.55–6.30) | 1.78 (0.55–5.70) | ||
| 2002 (percent) | 36.4 | 44.0 | 14.9 | 19.2 | 4.7 | 4.7 | 5.6 | 4.2 | ||
| 2013 (percent) | 21.1 | 21.8 | 14.4 | 12.2 | 6.2 | 6.8 | 2.4 | 1.8 | ||
| Ratio (2013/2002) | 0.58 (0.49–0.69) | 0.50 (0.44–0.56) | 0.97 (0.59–1.57) | 0.64 (0.48–0.85) | 1.33 (0.44–4.04) | 1.46 (0.44–4.86) | 0.44 (0.29–0.65) | 0.44 (0.27–0.70) | ||
| 0.001 | < 0.001 | 0.766 | 0.862 | 0.191 | 0.796 | 0.029 | 0.037 | |||
| Clinical | 2002 (percent) | 40.9 | 54.3 | 56.3 | 73.0 | 51.6 | 62.3 | 42.8 | 38.5 | |
| 2013 (percent) | 44.0 | 55.4 | 39.8 | 52.1 | 56.7 | 74.8 | 40.1 | 40.7 | ||
| Ratio (2013/2002) | 1.08 (0.88–1.32) | 1.02 (0.88–1.18) | 0.71 (0.64–0.79) | 0.71 (0.66–0.77) | 1.10 (0.93–1.29) | 1.20 (1.04–1.38) | 0.94 (0.79–1.11) | 1.06 (0.86–1.29) | ||
| 2002 (percent) | 47.5 | 46.3 | 42.2 | 48.2 | 37.7 | 42.5 | 31.5 | 23.9 | ||
| 2013 (percent) | 40.8 | 46.9 | 32.1 | 34.0 | 48.3 | 50.7 | 35.9 | 30.4 | ||
| Ratio (2013/2002) | 0.86 (0.72–1.03) | 1.01 (0.82–1.25) | 0.76 (0.64–0.91) | 0.71 (0.61–0.82) | 1.28 (0.95–1.72) | 1.19 (0.93–1.54) | 1.14 (0.84–1.56) | 1.27 (0.85–1.92) | ||
| 0.113 | 0.951 | 0.615 | 0.921 | 0.290 | 0.955 | 0.256 | 0.351 | |||